Investigating the efficacy of chest pressure for direct current cardioversion in atrial fibrillation: a randomised control trial protocol (Pressure-AF)
Enregistré dans:
Auteurs principaux: | David Ferreira, Nicholas Collins, Andrew Boyle, Thomas Ford, Nicholas Jackson, Aaron Sverdlov, James Leitch, Philo Mikhail, Michael McGee, Maged William, Malcolm Barlow, Bradley Wilsmore |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMJ Publishing Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e972b0b79c144d6db12e6ef3f9b04f4a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Predictive Value of Tissue Doppler Indices for Early Recurrence of Atrial Fibrillation After Electrical Cardioversion
par: Karaliute R, et autres
Publié: (2020) -
Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry
par: Krittayaphong R, et autres
Publié: (2021) -
Improvement in Atrial Fibrillation-Related Symptoms After Cardioversion: Role of NYHA Functional Class and Maintenance of Sinus Rhythm
par: Ferre-Vallverdu M, et autres
Publié: (2021) -
Modified Frailty as a Novel Factor in Predicting the Maintenance of the Sinus Rhythm After Electrical Cardioversion of Atrial Fibrillation in the Elderly Population
par: Mlynarska A, et autres
Publié: (2020) -
A Higher Polygenic Risk Score Is Associated with a Higher Recurrence Rate of Atrial Fibrillation in Direct Current Cardioversion-Treated Patients
par: Simon Vogel, et autres
Publié: (2021)